| Intitulé de poste
Sort ascending
|
Site |
Pays |
Division |
Business |
Functional Area |
Date de publication |
| VP, M&A Transactions |
Basel (City) |
Suisse |
Strategy & Growth |
Finance |
BDL et planification stratégique |
03 juin 2026 |
| VP, M&A Transactions |
Cambridge (Massachusetts) |
Etats-Unis |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
03 juin 2026 |
| Portfolio System Enablement Lead |
Hyderabad (Office) |
Inde |
Strategy & Growth |
Strategic Planning & BD&L |
Data and Digital |
28 mai 2026 |
| Executive Director M&A Transactions |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
Finance |
BDL et planification stratégique |
27 mai 2026 |
| Executive Director M&A Transactions |
Basel (City) |
Suisse |
Strategy & Growth |
Finance |
BDL et planification stratégique |
27 mai 2026 |
| Head of China C&BD |
Shanghai (Shanghai) |
Chine |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
26 mai 2026 |
| Senior Analyst - Forecasting |
Hyderabad (Office) |
Inde |
Strategy & Growth |
General Management |
Commercialisation |
14 mai 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
East Hanover |
Etats-Unis |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
08 mai 2026 |
| Director, Therapeutic Area Strategy, CRM |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
General Management |
BDL et planification stratégique |
28 avril 2026 |
| Director, Therapeutic Area Strategy, CRM |
Basel (City) |
Suisse |
Strategy & Growth |
General Management |
BDL et planification stratégique |
28 avril 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Basel (City) |
Suisse |
Strategy & Growth |
Other |
BDL et planification stratégique |
27 avril 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
Other |
BDL et planification stratégique |
27 avril 2026 |
| Therapeutic Area Strategy Director, Oncology & Hematology |
Basel (City) |
Suisse |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
27 avril 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
Basel (City) |
Suisse |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
21 avril 2026 |
No matching countries found
Rechercher